- $140.96bn
- $192.34bn
- $28.19bn
- 88
- 34
- 69
- 69
REG - Stock Exch Notice - Admission to ISM - 20/09/2024
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231005_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231005_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231005_HORIZON THERAPEUTICS PLC_38.5(b)_IE_BOFAS
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - D E Shaw & Co LP Horizon Therapeutics Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - D E Shaw & Co LP Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231004_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231004_HORIZON THERAPEUTICS PLC_38.5(b)_IE_BOFAS
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231004_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231003_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231003_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231003_HORIZON THERAPEUTICS PLC_38.5(b)_IE_MLPFS
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20231003_HORIZON THERAPEUTICS PLC_38.5(b)_IE_BOFAS
AnnouncementREG - D E Shaw & Co LP Horizon Therapeutics Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - D E Shaw & Co LP Horizon Therapeutics Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
Announcement